| Dr Richard C Good, MD | |
|
3240 Mount Moriah Ave, Owensboro, KY 42303-7805 | |
| (270) 926-4449 | |
| (270) 926-4554 |
| Full Name | Dr Richard C Good |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 32 Years |
| Location | 3240 Mount Moriah Ave, Owensboro, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710050760 | NPI | - | NPPES |
| 300061176 | Medicaid | IN | |
| 38081 | Other | KY | STATE LICENSE |
| 64066178 | Medicaid | KY | |
| 000000340420 | Other | KY | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VG0400X | Obstetrics & Gynecology - Gynecology | 38081 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Owensboro Health Regional Hospital | Owensboro, KY | Hospital |
| Entity Name | Owensboro Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235518242 PECOS PAC ID: 0648255034 Enrollment ID: O20040621000818 |
News Archive
Aggressive cancer cells spread from a tumour to another part of the body through the blood vessel. To be able get in and out of the blood vessel, the cancer cell needs to penetrate tissue. Researchers from The University of Bergen have discovered a protein that the cancer cell uses like scissors to cut up tissue, so it can spread from a tumour to a new organ.
Today, the FDA announced a final rule that provides a less-burdensome path to market for certain hardware and software products used with medical devices. The rule classifies these products, known as Medical Device Data Systems or MDDS, as Class I or low-risk devices, making them exempt from premarket review but still subject to quality standards.
Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for KRX-0401 (perifosine), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, for the treatment of refractory advanced colorectal cancer.
The strength of alpha brain waves reveals if you are about to make a biased decision, according to research recently published in JNeurosci.
In a new study from the Danish psychiatry project iPSYCH, researchers have identified genetic risk factors for developing bipolar disorder and psychoses among people with depression.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard C Good, MD 3240 Mount Moriah Ave, Owensboro, KY 42303-7805 Ph: (270) 926-4449 | Dr Richard C Good, MD 3240 Mount Moriah Ave, Owensboro, KY 42303-7805 Ph: (270) 926-4449 |
News Archive
Aggressive cancer cells spread from a tumour to another part of the body through the blood vessel. To be able get in and out of the blood vessel, the cancer cell needs to penetrate tissue. Researchers from The University of Bergen have discovered a protein that the cancer cell uses like scissors to cut up tissue, so it can spread from a tumour to a new organ.
Today, the FDA announced a final rule that provides a less-burdensome path to market for certain hardware and software products used with medical devices. The rule classifies these products, known as Medical Device Data Systems or MDDS, as Class I or low-risk devices, making them exempt from premarket review but still subject to quality standards.
Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for KRX-0401 (perifosine), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, for the treatment of refractory advanced colorectal cancer.
The strength of alpha brain waves reveals if you are about to make a biased decision, according to research recently published in JNeurosci.
In a new study from the Danish psychiatry project iPSYCH, researchers have identified genetic risk factors for developing bipolar disorder and psychoses among people with depression.
› Verified 6 days ago
Thomas N. Tabb, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1301 Pleasant Valley Rd, Suite 300, Owensboro, KY 42303 Phone: 270-417-7700 Fax: 270-417-7705 | |
Dr. Eric P. Griffin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2200 E Parrish Ave Ste 201, Owensboro, KY 42303 Phone: 270-926-3700 Fax: 270-926-0368 | |
Andrea B. Moore, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2200 E Parrish Ave, Bldg B Ste 201, Owensboro, KY 42303 Phone: 270-926-3700 Fax: 270-926-2114 | |
Ms. Kiesha Nicole Benn, MD, FACOG Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1301 Pleasant Valley Rd Ste 301, Owensboro, KY 42303 Phone: 270-417-7720 Fax: 270-417-7750 | |
Angela M Dawson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2200 E Parrish Ave, Bldg B Ste 201, Owensboro, KY 42303 Phone: 270-926-3700 Fax: 270-926-2114 | |
Dr. Ann L Clark, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2211 Mayfair Dr, Suite 305, Owensboro, KY 42301 Phone: 270-688-2018 Fax: 270-688-2029 | |
Dr. Catharine A. Schmitt, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2200 E Parrish Ave, Bldg B Ste 201, Owensboro, KY 42303 Phone: 270-926-3700 Fax: 270-926-2114 |